Why participate in a study?
Why participate in a study? Participating in a clinical study can offer several potential benefits, both for individuals and for society including your personal health, active involvement in your health care, advancing medical knowledge, and a chance to make a positive impact on the lives of others. We understand that participation is a personal decision and requires careful consideration. Our team is here to answer any questions you may have, and should you choose to participate, we will be with you every step of the way.
Please see our current studies below and contact us if you are interested in participating.
Post COVID-19 Neuro-Cognitive Manifestations and Underlying Mechanisms in Older African Americans (CCARE)
Keywords: COVID-19, African Americans, Dementia, Cognitive
This observational study explores the neurological and cognitive impact of COVID-19 infections in the African American population age 50+. The study will explore the relationship between medical conditions known to be risk factors (diabetes, high blood pressure) for Alzheimer’s disease (AD) and related dementias after COVID-19 infections. Researchers hope to gain a better understanding of how COVID-19 affects cognition or the brain’s function and what risk factors are associated with lasting cognitive impairment following COVID-19 infection.
Email to participate | Call: 469-852-5001 | View flyer
Remembrance Research Cohort (RRC) Study
Keywords: Dallas Heart Study, Lumbar Puncture, Memory Diseases, Cognitive, Heart and Memory
This study is inviting the all adults 18 years old and older and the Dallas Heart study participants for a one-time visit with the UT Southwestern Neurology Department. Our goal is to check how the heart might affect memory and the brain. In order to do that, we would like to perform a brief memory screen (if applicable) and check for signs of inflammation or excess protein in the brain which may lead to memory loss. To do this we will obtain a blood sample and a sample of your fluid that surrounds the brain. This procedure uses technology that is designed to minimize injury and pain. By enrolling, you are assisting us in understanding how the heart may affect memory which may help in better treatment of memory diseases.
Email to participate | Call: 469-852-5002
Metformin in Alzheimer's dementia Prevention (MAP) - STUDY IS CLOSED
Keywords: Metformin, Dementia Prevention, Study Site
This study is a 24 month long phase II/III 1:1 randomized clinical trial of extended-release Metformin (Glucophage XR [reduced mass]) 2000 mg (in 500 mg tablets) vs. matching placebo among 370 persons with amnestic mild cognitive impairment without diabetes in the prevention of cognitive decline among persons at risk for Alzheimer's dementia. Each participant will be assessed every six months for a total of 5 visits. If you are interested or know someone who maybe, please feel free to contact us using the link below to further discuss qualifications for this study.
Email to participate | Call: 469-852-5002